1. Chi JH, Bydon A, Hsieh P, Witham T, Wolinsky J, Gokaslan ZL. Epidemiology and demographics for primary vertebral tumors. J Spinal Disord. 2008;19:1-4.
2. Kelley SP, Ashford RU, Rao AS, Dickson RA. Primary bone tumours of the spine: a 42-year survey from the Leeds Regional Bone Tumour Registry. Eur Spine J. 2007;16(3):405-9.
3. Weinstein JN, McLain RF. Primary tumors of the spine. Spine (Phila Pa 1976). 1987;12(9):843-51.
4. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;(153):106-20.
5. Stuckey RM, Marco RA. Chondrosarcoma of the mobile spine and sacrum. Sarcoma. 2011;2011:274281.
6. Shives TC, Dahlin DC, Sim FH, Pritchard DJ, Earle JD. Osteosarcoma of the spine. J Bone Joint Surg Am. 1986;68(5):660-8.
7. Donthineni R. Diagnosis and staging of spine tumors. Orthop Clin North Am. 2009;40(1):1-7.
8. Chan P, Boriani S, Fourney DR, Biagini R, Dekutoski MB, Fehlings MG, et al. Reliability of Enneking and WBB classifications for staging primary spinal tumors: Spine Oncology Study Group. Spine (Phila Pa 1976). 2009;34(4):384-91.
9. Hsieh PC, Xu R, Sciubba DM, McGirt MJ, Nelson C, Witham TF, et al. Long-term outcomes following en bloc resections for sacral chordomas and chondrosarcomas. Spine (Phila Pa 1976). 2009;34(20):2233-9.
10. Wang VY, Potts M, Chou D. Sarcoma and the spinal column. Neurosurg Clin N Am. 2008;19(1):71-80.
11. Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine: terminology and surgical staging. Spine (Phila Pa 1976). 1997;22(9):1036-44.
12. Sundaresan N, Rosen G, Boriani S. Primary malignant tumors of the spine. Orthop Clin North Am. 2009;40(1):21-36.
13. Bohinski RJ, Rhines LD. Principles and techniques of en bloc vertebrectomy for bone tumors of the thoracolumbar spine: an overview. Neurosurg Focus. 2003;15(5):E7.
14. Kawahara N, Tomita K, Murakami H, Demura S. Total en bloc spondylectomy for spinal tumors: surgical techniques and related basic background. Orthop Clin North Am. 2009;40(1):47-63.
15. Truumees E, Dodwad SN, Kazmierczak CD. Preoperative embolization in the treatment of spinal metastasis. J Am Acad Orthop Surg. 2010;18(8):449-53.
16. Tomita K, Kawahara N, Murakami H, Demura S. Total en bloc spondylectomy for spinal tumors: improvement of the technique and its associated basic background. J Orthop Sci. 2006;11(1):3-12.
17. Fujimaki Y, Kawahara N, Tomita K, Murakami H, Ueda Y. How many ligations of bilateral segmental arteries cause ischemic spinal cord dysfunction? An experimental study in dogs. Spine (Phila Pa 1976). 2006;31(21):E781-9.
18. Sekhar LN, Natarajan SK, Manning T, Bhagawati D. The use of fibrin glue to stop venous bleeding in the epidural space, vertebral venous plexus, and anterior cavernous sinus: technical note. Neurosurgery. 2007;61(3 Suppl):E51.
19. Ilaslan H, Sundaram M, Unni KK, Dekutoski MB. Primary Ewing’s sarcoma of the vertebral column. Skeletal Radiol. 2004;33(9):506-13.
20. Camargo VP, Camargo OP. Sarcomas de partes ósseas. 1 ed. São Paulo: Atheneu; 2013.
21. Schuck A, Ahrens S, Paulussen M, Kuhlen M, Könemann S, Rübe C, et al. Local therapy in localized Ewing tumors: results of 1058 patients in the CESS/EICESS trials. Int J Radiat Oncol Biol Phys. 2003;55(1):168-77.
22. Saeter G, Bruland Ø, Follerås G, Boysen M, Høie J. Prognostic factors in primary osteosarcoma of the spine. J Clin Oncol. 1996;14(1):291-300.
23. Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006;125(4):555-81.
24. Graham GN, Browne H. Primary bony tumors of the pediatric spine. Yale J Biol Med. 2001;74(1):1-8.
25. Sharma H, Mehdi SA, MacDuff E, Reece AT, Jane MJ, Reid R. Paget sarcoma of the spine: Scottish Bone Tumor Registry experience. Spine (Phila Pa 1976). 2006;31(12):1344-50.
26. Khalfallah M, Malca S, Roche PH, Duffaud F, Soumare O, Garbe L, et al. Primary spinal osteosarcomas. Neurochirurgie. 1997;43(1):28-34.
27. Ilaslan H, Sundaram M, Unni KK, Shives TC. Primary vertebral osteosarcoma: imaging findings. Radiology. 2004;230(3):697-702.
28. DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, et al. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005;61(2):492-8.
29. York JE, Berk RH, Fuller GN, Rao JS, Abi-Said D, Wildrick DM, et al. Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg. 1999;90(1 Suppl):73-8.
30. Boriani S, Saravanja D, Biagini R, Fisher CG. Challenges of local recurrence and cure in low-grade malignant tumors of the spine. Spine (Phila Pa 1976). 2009;34(22):25-32.
31. Boriani S, De Iure F, Bandiera S, Campanacci L, Biagini R, Di Fiore M, et al. Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976). 2000;25(7):804-12.
32. Katonis P, Alpantaki K, Michail K, Lianoudakis S, Christoforakis Z, Tzanakakis G, et al. Spinal chondrosarcoma: a review. Sarcoma. 2011;2011:378957.
33. Foweraker KL, Burton KE, Maynard SE, Jena R, Jefferies SJ, Laing RJC, et al. High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: Part 1 – Clinical outcomes. Clin Oncol (R Coll Radiol). 2007;19(7):509-16.
34. Moojen WA, Vleggeert-Lankamp CL, Krol AD, Dijkstra SP. Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable. Spine (Phila Pa 1976). 2011;36(10):E656-61.
35. Oitment C, Bozzo A, Martin AR, Rienmuller A, Jentzsch T, Aoude A, et al. Primary sarcomas of the spine: population-based demographic and survival data in 107 spinal sarcomas over a 23-year period in Ontario, Canada. Spine J. 2021;21(2):296-301.
36. Kerr DL, Dial BL, Lazarides AL, Catanzano AA, Lane WO, Blazer DG, et al. Epidemiologic and survival trends in adult primary bone tumors of the spine. Spine J. 2019;19(12):1941-1949.
37. Wang J, Ni XZ, Yang ML, Huang X, Hou SM, Peng C, et al. Prognostic factors and treatment outcomes of spinal osteosarcoma: Surveillance, Epidemiology, and End Results database analysis. Front Oncol. 2023;13:1083776.
38. Arshi A, Sharim J, Park DY, Park HY, Yazdanshenas H, Bernthal NM, et al. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine. Spine J. 2017;17(5):645-55.
39. Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results database from 1973 to 2003. J Neurosurg Spine. 2011;14(2):143-50.
40. Ong W, Lee A, Tan WC, Fong KTD, Lai DD, Tan YL, et al. Oncologic applications of artificial intelligence and deep learning methods in CT spine imaging – a systematic review. Cancers (Basel). 2024;16(17):2988.
41. Wilson SB, Ward J, Munjal V, Lam CSA, Patel M, Zhang P, et al. Machine learning in spine oncology: a narrative review. Global Spine J. 2025;15(1):210-27.
42. Gitto S, Cuocolo R, Huisman M, Messina C, Albano D, Omoumi P, et al. CT and MRI radiomics of bone and soft-tissue sarcomas: an updated systematic review of reproducibility and validation strategies. Insights Imaging. 2024;15(1):54.
43. Lee YS, Cho DC, Kim KT. Navigation-guided/robot-assisted spinal surgery: a review article. Neurospine. 2024;21(1):8-17.
44. Sundaram PPM, Peh DYY, Poh JW, Kalanchiam GP, Yap WMQ, Kaliya-Perumal AK, et al. Does robotic spine surgery add value to surgical practice over navigation-based systems? A study on operating room efficiency. Medicina (Kaunas). 2024;60(12):2112.
45. Wang X, Sun S, Jiang Y, Ren B, Zhang X, Miao J, et al. Early clinical efficacy of 3D-printed artificial vertebral body in spinal reconstruction after total en bloc spondylectomy for spinal tumors. BMC Musculoskelet Disord. 2024;25(1):926.
46. Seidensaal K, Froehlke A, Lentz-Hommertgen A, Lehner B, Geisbuesch A, Meis J, et al. Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): an open label, randomized, stratified, phase II trial. Radiother Oncol. 2024;198:110418.
47. Fu Y, Xu Y, Liu W, Zhang J, Wang F, Jian Q, et al. Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. EClinicalMedicine. 2024;73:102697.
48. Tap WD, Villalobos VM, Cote GM, Burris H, Janku F, Mir O, et al. Phase I study of the mutant IDH1 inhibitor ivosidenib: safety and clinical activity in patients with advanced chondrosarcoma. J Clin Oncol. 2020;38(15):1693-701.
49. Lipplaa A, Strauss SJ, Stacchiotti S, Kayani I, Efthymiadis K, Frezza A, et al. A phase 2, single arm, European multi-center trial evaluating the efficacy of afatinib as first line or later line treatment in advanced chordoma. J Clin Oncol. 2024;42(16_suppl):11517.